Autres langues

18:08 FTSE 100 drifts lower in mixed day for Europe
13:07 FTSE 100 underwhelms in tepid end to week
11:09 WINNERS & LOSERS: Michael Page higher on UBS lift; software shares up
13/08 FTSE 100 down, peers rise as Fed hike bets cool
13/08 WINNERS & LOSERS: Anto cuts output view; BP, Shell, others ex-dividend
12/08 A No to BMS can open doors for a Yes to GSK
12/08 Trump's goal to split MMR vaccine could take a decade, experts say
12/08 WINNERS & LOSERS: Grocers down on drought worries; Balfour ups outlook
11/08 Global drugmakers invest billions to boost US presence
11/08 Trump streicht Empfehlungen für Kinderimpfungen zusammen
10/08 WINNERS & LOSERS: Threat to Vistry; Plus500 plans more share buybacks
06/08 LifeMine Therapeutics, Inc. announced that it has received $188 million in funding from a group of investors
06/08 US FDA approves first mRNA flu shot from Moderna
04/08 Merck's Weekly HIV Treatment Pipeline 'Interesting,' UBS Says
04/08 ViiV Healthcare Launches “Do It For Future You” Campaign Inspiring People to Prioritize Their Sexual Health and Future
03/08 GSK India first-quarter profit rises on steady vaccine demand
03/08 RBC cuts JD Sports; Jefferies cuts Severn Trent
30/07 Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US
30/07 GSK global supply chain director sells 38,000 shares
30/07 GSK, Relation Therapeutics to Collaborate on Human Cellular Perturbation Data
30/07 GSK, Relation Therapeutics sign up to $110 million AI drug discovery deal
30/07 WINNERS & LOSERS: Rolls-Royce ups guide; Rentokil slumps
30/07 Relation Therapeutics Limited and Glaxosmithkline plc Announce Expanded Collaboration to Generate Large-Scale Human Cellular Perturbation Datasets
30/07 Berenberg raises Rio Tinto; HSBC ups Centrica
30/07 GSK, Relation Therapeutics Collaborate on Human Cellular Data Project
Aucun résultat pour cette recherche